0001654954-22-000128.txt : 20220104
0001654954-22-000128.hdr.sgml : 20220104
20220104143121
ACCESSION NUMBER: 0001654954-22-000128
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220101
FILED AS OF DATE: 20220104
DATE AS OF CHANGE: 20220104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tsuchimoto Kim R
CENTRAL INDEX KEY: 0001333516
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39070
FILM NUMBER: 22505293
MAIL ADDRESS:
STREET 1: C/O MONOPAR THERAPEUTICS INC.
STREET 2: 1000 SKOKIE BLVD., SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Monopar Therapeutics
CENTRAL INDEX KEY: 0001645469
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320463781
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 SKOKIE BLVD SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
BUSINESS PHONE: 8473880349
MAIL ADDRESS:
STREET 1: 1000 SKOKIE BLVD SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
4
1
section16.xml
PRIMARY DOCUMENT
X0306
4
2022-01-01
false
0001645469
Monopar Therapeutics
MNPR
0001333516
Tsuchimoto Kim R
1000 SKOKIE BLVD SUITE 350
WILMETTE
IL
60091
false
true
false
false
Chief Financial Officer
Common Stock
2022-01-01
4
M
false
1231
A
5420
D
Common Stock
2022-01-01
4
F
false
505
3.21
D
4915
D
Restricted Stock Units
2022-01-01
4
M
false
1231
0
D
Common Stock
1231
2461
D
Represents shares acquired on vesting and settlement of restricted stock units.
On January 31, 2020 the reporting person was granted 4,923 restricted stock units, vesting in four equal annual installments with vesting dates on January 1, 2021, January 1, 2022, January 1, 2023, and January 1, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
/s/ Kim R. Tsuchimoto
2022-01-04